Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1983-06-20
1985-03-26
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 46, 514859, 514947, A61K 3170
Patent
active
045072876
ABSTRACT:
There is disclosed a preparation and method of treating Acne vulgaris which comprises topical application of a preparation comprising an antibacterial agent dissolved in DMSO. The antibacterial agents include ara-A, acyclovir, ribavirin, amikacin, cefamandole, cefoxitin, erythromycin, tetracycline, tobramycin, vancomycin, lincomycin, and carbenicillin.
REFERENCES:
patent: 3551554 (1970-12-01), Herschler
patent: 3711602 (1973-01-01), Herschler
patent: 3743727 (1973-07-01), Herschler
patent: 4081534 (1978-03-01), Elion et al.
patent: 4150114 (1979-04-01), Smith
patent: 4199574 (1980-04-01), Schaeffer
patent: 4211771 (1980-07-01), Witkowski et al.
Chemical Abstracts, vol. 93; (1980), #101442w; Klein et al.
The Merck Index; 9th edition, (1976), #3602, 7991, 8913 and A15.
Dixon et al., 1969, "Antiviral Activity of 9-B-D-Arabinofuranosyladenine, V. Activity Against Intracerebral Vaccina Virus Infections in Mic," Antimicrobial Agents and Chemotherapy, pp. 172-179.
Sidwell et al., 1969, "Antiviral Activity of 9-B-D-Arabinofuranosyladenine, II. Activity Against Herpes Simplex Keratitis in Hamsters", Antimicrobial Agents and Chemotherapy, pp. 148-154.
Schardein et al., 1969, "Antiviral Activity of 9-B-D-Arabinofuranosyladenine, III. Reduction in Evidence of Encephalitis in Treated Herpes Simplex-Infected Hamsters", Antimicrobial Agents and Chemotherapy, pp. 155-160.
Sloan et al., 1969, "Antiviral Activity of 9-B-D-Arabinofuranosyladenine, IV. Activity Against Intracerebral Herpes Simplex Virus Infections in Mice," Antimicrobial Agents and Chemotherapy, pp. 161-171.
Hilton et al., Feb. 1978, "A Trial of Adenine Arabinoside in Genital Herpes," British Journal of Veneral Diseases, pp. 50-52.
Goodman et al., 1975, "Prospective Double-Blind Evaluation of Topical Adenine Arabinoside in Male Herpes Progenitalis," Antimicrobial Agents and Chemotherapy, vol. 8, No. 6, pp. 693-697.
MacCallum et al., Oct. 1, 1966, "Herpes Simplex Virus Skin Infection in Man Treated with Idoxuridine in Dimethyl Sulphoxide, Results of Double-Blind Controlled Trial," British Medical Journal, pp. 805-807.
Turnbull et al., Nov. 1969, "The Enhancing Effect of Dimethylsulfoxide Vehicle upon the Anti-Viral Actions of 5-Iododeoxyuridine," New Zealand Medical Journal, pp. 317-320.
Juel-Jensen et al., Dec. 1970, "Treatment of Zoster with Idoxuridine in Dimethyl Sulphoxide, Results of Two Double-Blind Controlled Trials," British Medical Journal, vol. 4, pp. 776-780.
Thormann et al., 1980, "Contact Allergy to Idoxuridine, Sensitization Following Treatment of Herpes Zoster," Contact Dermatitis, vol. 6, pp. 170-171.
Burton et al., Nov. 25, 1981, "On Trial, A Multicentre Trial of Zostrum (5 Percent Idoxuridine in Dimethylsulphoxide) in Herpes Zoster," New Zealand Medical Journal, pp. 384-386.
Silvestri et al., Aug. 27, 1982, "Ineffectiveness of Topical Idoxuridine in Dimethyl Sulfoxide for Therapy for Genital Herpes," JAMA, vol. 248, No. 8, pp. 953-959.
Spruance et al., 1983, "Dimethyl Sulfoxide as a Vehicle for Topical Antiviral Chemotherapy," Annals of the New York Academy of Sciences, pp. 1-14.
Cohrs William R.
Lipovsky Joseph A.
Lischer Dale
Lunsford III J. Rodgers
Schenkman Leonard
LandOfFree
Preparation and method for the treatment of acne does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation and method for the treatment of acne, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation and method for the treatment of acne will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1293706